Wealth Enhancement Advisory Services’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.7K | Buy |
90,550
+21,300
| +31% | +$11.2K | ﹤0.01% | 3205 |
|
|
2025
Q1 | $45.4K | Sell |
69,250
-53,213
| -43% | -$34.9K | ﹤0.01% | 2827 |
|
|
2024
Q4 | $125K | Buy |
122,463
+13,518
| +12% | +$13.8K | ﹤0.01% | 2749 |
|
|
2024
Q3 | $94.4K | Buy |
108,945
+38,850
| +55% | +$33.6K | ﹤0.01% | 2535 |
|
|
2024
Q2 | $25.1K | Buy |
70,095
+21,000
| +43% | +$7.52K | ﹤0.01% | 2457 |
|
|
2024
Q1 | $32.9K | Buy |
49,095
+14,095
| +40% | +$9.45K | ﹤0.01% | 2344 |
|
|
2023
Q4 | $19K | Buy |
+35,000
| New | +$19K | ﹤0.01% | 2237 |
|